Stocksigma LogoStocksigma Logo

Jagsonpal Pharmaceuticals Schedules Board Meeting for Q2 Earnings on 28th Oct'26

Jagsonpal Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 28th Oct'26 to consider and approve the standalone and consolidated

Jagsonpal Pharmaceuticals Schedules Board Meeting for Q2 Earnings on 28th Oct'26

Jagsonpal Pharmaceuticals Ltd 路 Intimation 路 28 Oct 2026, 5:30 am

Jagsonpal Pharmaceuticals Schedules Board Meeting for Q2 Earnings on 28th Oct'26 Jagsonpal Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 28th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter ended 30th Sep'26. Additionally, the company's trading window for dealing in its securities will remain closed until 30th Oct'26, in continuation of its prior intimation dated 25th Sep'26.

Original exchange filing (PDF)

More announcements from Jagsonpal Pharmaceuticals Ltd

All Jagsonpal Pharmaceuticals Ltd announcements